8-K Announcements
6Material company update
Jun 18, 2026·SEC
Material company update
Jun 3, 2026·SEC
Material company update
May 14, 2026·SEC
Tivic Health Systems, Inc.(TIVC)Earnings, Financials & Key Ratios
TIVC•NASDAQ
$0.50
Price updated Jul 7, 2026
AboutTivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.Show more
- Revenue$382K-51.0%
- EBITDA-$8M-48.7%
- Net Income-$9M-57.0%
- EPS (Diluted)-7.84+60.1%
- Gross Margin-1.31%-610.5%
- EBITDA Margin-2066.23%-203.6%
- Operating Margin-2067.54%-184.9%
- Net Margin-2324.08%-220.6%
- ROE-91.85%+50.3%
TIVC Price & Volume
Tivic Health Systems, Inc. (TIVC) stock price & volume — 10-year historical chart
Loading chart...
Revenue Collapse Signals Severe Structural Business Failure
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Capital structure insolvency risk
Key Thesis Takeaways
- Tivic Health Systems faces a critical existential threat as evidenced by the total revenue contraction to zero in 2026Q1 and a persistent inability to achieve positive unit economics.
- The company's reliance on high-burn R&D and SG&A spending, which totaled $5.7 million in 2026Q1, continues to erode shareholder equity without delivering a scalable commercial product.
- Investors should remain cautious as the company's debt-to-equity ratio has surged to 1.54, significantly increasing the risk of insolvency in the absence of a viable path to profitability.
Verdict Logic
the company's fundamental instability is highlighted by a 2026Q1 net loss of $6.2 million and a debt-to-equity ratio that has climbed to 1.54, suggesting an unsustainable capital structure.
TIVC Growth Metrics
Tivic Health Systems, Inc. (TIVC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-14.98%
3 Years-40.79%
TTM-113.57%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-139.22%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM51.46%
Return on Capital
10 Years-146.58%
5 Years-125.7%
3 Years-145.32%
Last Year-47.16%
TIVC Recent Earnings
Tivic Health Systems, Inc. (TIVC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (78%)●Beat Revenue 0/12 qtrs (0%)
Q4 2025Latest
Nov 14, 2025Metric
Actual
Est
EPS
$1.97
—
Rev
$146,000
—
Q3 2025
Aug 14, 2025Metric
Actual
Est
EPS
$2.19
—
Rev
$86,000
—
Q2 2025
May 15, 2025Metric
Actual
Est
EPS
$2.52
—
Rev
$70,000
—
Q2 2025
Mar 21, 2025Metric
Actual
Est
EPS
$15.42+81.9%
$85.00
Rev
$180,000-87.4%
$1M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2025Latest | Nov 14, 2025 | $1.97 | $146,000 |
| Q3 2025 | Aug 14, 2025 | $2.19 | $86,000 |
| Q2 2025 | May 15, 2025 | $2.52 | $70,000 |
| Q2 2025 | Mar 21, 2025 | $15.42vs $85.00+81.9% | $180,000vs $1M-87.4% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Tivic Health Systems, Inc. (TIVC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.50 | $1.44M | -0.06 | -51.03% | -2324.08% | -91.85% | — | |
| $45.70 | $378.4M | 53.14 | 16.97% | 14.08% | 22.14% | — | |
| $1.35 | $93.94M | -2.29 | 99.17% | -24.48% | -139.83% | — | |
| $150.65 | $8.82B | -45.93 | 32.33% | -34.34% | -26.46% | — | |
| $83.58 | $4.59B | -18.78 | 10.74% | 7.47% | 9.13% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — |
Compare TIVC vs Peers
Tivic Health Systems, Inc. (TIVC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
TIVC SEC Filings & Documents
Tivic Health Systems, Inc. (TIVC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when TIVC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
TIVC Frequently Asked Questions
Tivic Health Systems, Inc. (TIVC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Tivic Health Systems, Inc.'s revenue?
Tivic Health Systems, Inc. (TIVC) reported $-0.1M in revenue for fiscal year 2025. This represents a 117% decrease from $0.4M in 2019.
How fast is Tivic Health Systems, Inc. growing?
Tivic Health Systems, Inc. (TIVC) saw revenue decline by 51.0% over the past year.
Is TIVC profitable?
Tivic Health Systems, Inc. (TIVC) reported a net loss of $13.6M for fiscal year 2025.
Dividend & Returns
What is TIVC's return on equity?
Tivic Health Systems, Inc. (TIVC) has a return on equity (ROE) of -91.8%. Negative ROE indicates the company is unprofitable.
What is Tivic Health Systems, Inc.'s free cash flow?
Tivic Health Systems, Inc. (TIVC) had negative free cash flow of $11.2M in fiscal year 2025, likely due to heavy capital investments.